Dr Dawson is chief of Adolescent Medicine Services, Carl R Darnall Army Medical Center Pediatric Clinic, Fort Hood, Texas.

Mark R. Corkins, MD, CNSC, FASPEN, AGAF, FAAP, reviews where pediatric probiotic evidence is strongest, why product quality varies, and which children should avoid them. Evidence supporting probiotic ...

Alex R. Kemper, MD, MPH, MS | Authors | Contemporary Pediatrics connects pediatricians with peer-reviewed articles, guideline updates, and practice strategies for real-world clinical application.

Among 67 families who completed the study, adherence was 100% across 8 osteopathic manipulative treatment (OMT) visits and 2 measurement visits. No serious adverse events occurred during the ...

A first-in-human phase 1 trial is evaluating the safety and tolerability of a microneedle stamp that delivers controlled doses of peanut protein through the skin. The nickel-sized device is applied ...

AAP’s 2026 conference will bring pediatricians updates on AI, vaccines, misinformation, nutrition, mental health, and clinical care. Pediatricians gathering in San Diego for the American Academy of ...

More than half of firearm-owning families with children aged 1 to 5 years reported that at least 1 household firearm was stored unlocked, loaded, or both. Secure storage was reported by 41.5% of ...

FDA accepts leniolisib sNDA with priority review for children with APDS aged 4+ weighing 13 to <27 kg; PDUFA date is January 30, 2027. Children with activated phosphoinositide 3-kinase δ syndrome ...

Higher baseline Severity of Alopecia Tool (SALT) scores were associated with lower odds of response to methotrexate, Janus kinase (JAK) inhibitors, and oral minoxidil. JAK inhibitors had the highest ...

Aquestive resubmitted its NDA for dibutepinephrine sublingual film Anaphylm, citing new human factors and PK data addressing the FDA's CRL. Aquestive Therapeutics has resubmitted its New Drug ...

Melissa Wallach, MD, FAAP, discusses what pediatricians should know about updated screening, supplementation, and treatment recommendations for iron deficiency. New guidance from the American Academy ...

The FDA approved 40 mg and 50 mg twice-daily leniolisib (Joenja) for children ages 4 to 11 years weighing at least 27 kg with activated PI3Kδ syndrome. According to a new announcement from Pharming, ...